Treatment Information

Back

Mesothelioma treatment details. Immunotherapy.

Ospedale S. Spirito, Casale Monferrato, Italy.

Survival: monthsCountry:Italy
Toxiciy Grade:3City/State/Province:Casale Monferrato
Treatments:ImmunotherapyHospital:Ospedale S. Spirito
Drugs:Journal:Link
Date:Feb 2001

Description:

Patients: This Phase II study involved 31 patients with malignant pleural mesothelioma.

Treatment: The treatment consisted of the injection of human recombinant Interleukin-2 (Proleukin).

Toxicity: Grade 3 toxicities included cardiac failure and fever. Grade 2 toxicities included neuropathy, neurologic, and gastrointestinal.

Results: Median overall survival was 15 months.

Correspondence: Bruno Castagneto, MD





Back